Genome-wide association studies (GWAS) showed that polymorphisms in the Tfh signature genes IL-21 (135), CXCR5 (136), and PD-1 (137) are either diagnostic or prognostic risk factors for MS. Here, IL21 is linked to myeloid sarcoma.